Announcements Trials
Browse Landscape

Status

Completed 5Unknown 4Recruiting 3Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 141Neoplasms 132Prostatic Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Lung Neoplasms 67Colorectal Neoplasms 47Carcinoma, Hepatocellular 37Stomach Neoplasms 32Multiple Myeloma 29Brain Neoplasms 28Uterine Cervical Neoplasms 27Pancreatic Neoplasms 26Ovarian Neoplasms 26Melanoma 25Head and Neck Neoplasms 25Rectal Neoplasms 24Colonic Neoplasms 24Urinary Bladder Neoplasms 22Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Lymphoma 15Liver Neoplasms 15Cardiovascular Diseases 15COVID-19 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Fatty Liver × Clear all
NCT05165446 2026-04-23

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Stanford University

Active not recruiting
35 enrolled

Fatty Liver, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡